Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H18FN3O3 |
Molecular Weight | 331.3415 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CN(C2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
InChI
InChIKey=MYSWGUAQZAJSOK-UHFFFAOYSA-N
InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)
Molecular Formula | C17H18FN3O3 |
Molecular Weight | 331.3415 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:12:49 UTC 2023
by
admin
on
Sat Dec 16 05:12:49 UTC 2023
|
Record UNII |
5E8K9I0O4U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
422314
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-VATC |
QJ01MA02
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
NDF-RT |
N0000175937
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
NDF-RT |
N0000007606
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
216905
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
S01AE03
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/07/469
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
S02AA15
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
S03AA07
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
297209
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-VATC |
QS01AE03
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
718519
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
230806
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
339911
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.2
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
NCI_THESAURUS |
C795
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
S01AX13
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
J01MA02
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
J01RA12
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
J01RA10
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-VATC |
QS03AA07
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-VATC |
QS02AA15
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
LIVERTOX |
NBK548066
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ATC |
J01RA11
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
28
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
369812
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D002939
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
DB00537
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
CIPROFLOXACIN
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
CHEMBL8
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
2551
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | RxNorm | ||
|
CIPROFLOXACIN
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | Description: A white to pale yellow, crystalline powder.Solubility: Practically insoluble in water; very slightly soluble in ethanol (~750 g/l) TS and dichloromethane R.Category: Antibacterial.Storage: Ciprofloxacin should be kept in a well-closed container, protected from light.Additional information: Ciprofloxacin exists in different polymorphic forms. | ||
|
5E8K9I0O4U
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
100000092110
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
85721-33-1
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
100241
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
C375
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
m3583
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | Merck Index | ||
|
Y-54
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
659
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
2764
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
DTXSID8022824
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
6987
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
SUB07470MIG
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
5E8K9I0O4U
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
758467
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
5446
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
1134313
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY | |||
|
Ciprofloxacin
Created by
admin on Sat Dec 16 05:12:50 UTC 2023 , Edited by admin on Sat Dec 16 05:12:50 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
|
||
|
SOLVATE->ANHYDROUS | |||
|
TRANSPORTER -> INHIBITOR |
IC50
|
||
|
TRANSPORTER -> INHIBITOR |
IC50
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE LESS ACTIVE -> PARENT |
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL, EXTENDED-RELEASE PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
PROTEIN BINDING (SERUM PROTEINS) | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
NEONATES PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Route of Elimination | PHARMACOKINETIC |
|
FECAL PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||